The Traderszone Network

Published in TZ Latest News 29 January, 2016 by The TZ Newswire Staff

Merck’s Hepatitis C Doublet Wins FDA Approval and Unveils Its Secret Weapon

Merck’s newly-approved hepatitis C drug has an interesting plan of attack when it comes to taking market share from Gilead Sciences and AbbVie.